Article

Symposium on Transforming Cancer Care in Hudson County Set for December 3 at Hackensack Meridian Health Palisades Medical Center

Author(s):

Event Name

:

Transforming Cancer Care in Hudson County

Agenda and Featured Speakers:

John Theurer Cancer Center Updates

Andre Goy, M.D., Chairman & Executive Director, Chief, Lymphoma Division, John Theurer Cancer Center

Novel Therapies in Cancer

Martin Gutierrez, M.D., Director, Drug Discovery and the Phase I Unit, Chief, Thoracic Oncology Division, John Theurer Cancer Center

Cancer Prevention and Control in Bergen and Hudson County

Paula Cupertino, Ph.D., Director, Center for Cancer Disparities, John Theurer Cancer Center

Center for Discovery Updates

Benjamin Tycko, M.D., Ph.D., Member, Center for Discovery and Innovation, Hackensack Meridian Health

Date/Time:

Tuesday, December 3, 5:30 p.m. to 8:30 p.m.

Location:

Hackensack Meridian Health Palisades Medical Center, Auditorium, 7600 River Road, North Bergen

Who:

All physicians and healthcare providers/professionals in Hudson County area are welcome to attend.

Cost:

FREE Admission. FREE Parking. FREE refreshments will be provided.

Registration:

Visit JTCancerCenter.org/TransformingCancerCare

Related Videos
Andrew Ip, MD
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the treatment goals in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss factors for picking intensive chemotherapy vs other regimens in acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss long-term data for CPX-351 in acute myeloid leukemia.
James K. McCloskey, MD, and Harry P. Erba, MD, PhD, discuss factors to help determine intensive chemotherapy fitness in acute myeloid leukemia.
James K. McCloskey, MD, and Harry P. Erba, MD, PhD, discuss the diagnosis and prevalence of secondary acute myeloid leukemia.
David Samuel Dicapua Siegel, MD
Noa Biran, MD